Table 1.
Characteristics of the study group and comparisons between group with PA-EE below and above median.
| Subjects with PA-EE <Me N = 150 |
Subjects with PA-EE ≥Me N = 150 |
|
|---|---|---|
| Age [years] | 63 (62–64) | 63 (61–64) |
| Education [years] | 13 (12–17) | 13 (12–15) |
| BMI [kg/m2] | 27.71 (25.27–30.55) | 27.86 (24.77–31.27) |
| WHR | 0.93 (0.84–1.00) | 0.93 (0.85–1.00) |
| WHtR | 0.57 (0.53–0.61) | 0.57 (0.52–0.63) |
| Obesity (BMI ≥ 30 kg/m2) | 48 (32%) | 47 (31%) |
| PA-EE [kcal/kg/day] | 39.14 (36.53–40.75) | 50.41 (46.71–54.85) *** |
| PA-HRB I | 3.0 (1.0–4.0) | 3.0 (2.0–4.0) * |
| PA-HRB II (at least 1); n (%) | 12 (8%) | 35 (23.3%) * |
| SBP [mmHg] | 135 (123–145) | 136.5 (127–150) |
| DBP [mmHg] | 82 (75–93) | 84 (75–92) |
| Pulse[/min] | 67 (62–72) | 66.5 (62–72) |
| Blood platelets [103/mm3] | 207.5 (180.0–239.5) | 214 (181–252) |
| Total cholesterol [mg/dL] | 202.15 (170.2–231.2) | 205.6 (172.5–244.5) |
| LDL cholesterol [mg/dL] | 125.6 (100.8–151.1) | 126.5 (100.7–160.7) |
| HDL cholesterol [mg/dL] | 48.3 (40.2–57.1) | 48.05 (41.4–58.4) |
| Triglycerides [mg/dL] | 111.7 (82.6–155.8) | 110.1 (72.6–165.6) |
| Glucose [mg/dL] | 99.2 (90.7–108.3) | 100.6 (92.6–113.5) |
| Uric acid [mg/dL] | 5.0 (4.1–5.8) | 4.7(4.0–5.6) |
| Homocysteine [µmol/L] | 15.0 (13.2–17.3) | 14.0 (12.1–16.8) * |
| vWF [µg/mL] | 5.54 (4.91–6.09) | 5.45 (4.84–6.21) |
| VCAM [ng/mL] | 269.0 (246.5–297.0) | 274.2 (253.4–300.2) |
| ICAM [ng/mL] | 209.0 (202.9–218.3) | 211.7 (202.9–219.1) |
| TXB2s [pg/mL] | 8.41 (7.44–8.88) | 8.18 (7.42–8.91) |
| TXB2d [pg/mL] | 9.03 (8.12–9.58) | 8.87 (7.9–9.64) |
* p < 0.05; *** p < 0.001; significantly different in comparison with the group with PA-EE below median (Me). Data presented as median (lower-upper quartile). Comparisons between group with PA-EE below and above median were performed with the use of the Mann–Whitney U test, the χ2 test or the Fisher exact χ2 test. Abbreviations: BMI: body mass index; WHR: waist–hip ratio; WHtR: waist–height ratio; PA-EE: physical activity–energy expenditure; PA-HRBI: physical activity-moderate health related behaviors; PA-HRBII: physical activity-intensive health-related behaviors; SBP: systolic blood pressure; DBP: diastolic blood pressure; LDL-cholesterol: low-density lipoprotein cholesterol, HDL-cholesterol: high-density lipoprotein cholesterol; vWF: von Willebrand factor; VCAM-1: vascular cell adhesion protein 1; ICAM-1: intracellular adhesion molecule 1; TXB2s- thromboxane 2 generated in static conditions; TBX2d thromboxane 2 generated in dynamic conditions; TAS: total antioxidant status; TOS: total oxidative status.